EORTC Radiotherapy Group: achievements and future projects. European Organisation for Research and Treatment of Cancer.
The European Organisation for Research and Treatment of Cancer (EORTC) Radiotherapy (RT) Group will celebrate 27 years of activity in 2002. During its long history, the Radiotherapy Group has conducted a large number of studies which have provided valuable information on the radiation treatment of several disease sites. Group efforts have been concentrated on dose-effect studies, optimal fractionation schemes, combinations with other treatment modalities, and new radiotherapy techniques. The EORTC RT Group was the first in Europe to develop and introduce methodologies of Quality Assurance in radiotherapy. The RT Group actively collaborates with other EORTC Groups and international organisations. Currently, several phase III studies are being conducted in collaboration with European, North American and Australian organisations. The collaboration with RTOG led to the setting up of common systems for scoring late normal tissue effects. In the years to come, the Group will keep pioneering pivotal trials in radiotherapy and radio-chemotherapy. It will also explore combinations with novel therapies in phase I trials and implement innovative translational research programmes.
Budach
V
V
Klinik für Strahlentherapie, Universitätsklinikum (Charite)-Humboldt Universität, Schumannstrasse 20-21, 10117, Berlin, Germany.
Zurlo
A
A
Horiot
J C
JC
D001943:Breast Neoplasms / Q000532:radiotherapy; D005060:Europe; D005260:Female; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D007390:International Agencies / Q000458:organization & administration* / Q000639:trends; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy; D018787:Radiation Oncology / Q000458:organization & administration* / Q000639:trends; D011878:Radiotherapy / Q000639:trends; D016032:Randomized Controlled Trials as Topic